Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Cecile Rose T. Vibat"'
Autor:
Ryan D. Gentzler, John Guittar, Akash Mitra, Wade T. Iams, Terri Driessen, Regina Schwind, Michelle M. Stein, Kristiyana Kaneva, Seung Won Hyun, Yan Liu, Adam J. Dugan, Cecile Rose T. Vibat, Chithra Sangli, Jonathan Freaney, Zachary Rivers, Josephine L. Feliciano, Christine Lo, Kate Sasser, Rotem Ben-Shachar, Halla Nimeiri, Jyoti D. Patel, Aadel A. Chaudhuri
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 509-524 (2024)
Abstract Introduction A dynamic molecular biomarker that can identify early efficacy of immune checkpoint inhibitor (ICI) therapy remains an unmet clinical need. Here we evaluate if a novel circulating tumor DNA (ctDNA) assay, xM, used for treatment
Externí odkaz:
https://doaj.org/article/e9866030c92c41cc8282109a54d5780e
Autor:
Megan R. Reed, A. Geoffrey Lyle, Annick De Loose, Katrina Learned, Cecile Rose T. Vibat, Christopher P. Wardell, Robert L. Eoff, Olena M. Vaske, Analiz Rodriguez
Publikováno v:
Journal of Clinical and Translational Science, Vol 6, Pp 58-58 (2022)
OBJECTIVES/GOALS: A functional precision medicine platform to identify therapeutic targets for a glioblastoma patient with Li Fraumeni syndrome was performed. Comparative transcriptomics identified druggable targets and patient derived organoids and
Externí odkaz:
https://doaj.org/article/c2c3317ab6de45a186e45d9014a1a342
Autor:
Megan R. Reed, A. Geoffrey Lyle, Annick De Loose, Leena Maddukuri, Katrina Learned, Holly C. Beale, Ellen T. Kephart, Allison Cheney, Anouk van den Bout, Madison P. Lee, Kelsey N. Hundley, Ashley M. Smith, Teresa M. DesRochers, Cecile Rose T. Vibat, Murat Gokden, Sofie Salama, Christopher P. Wardell, Robert L. Eoff, Olena M. Vaske, Analiz Rodriguez
Publikováno v:
Cells, Vol 10, Iss 12, p 3400 (2021)
Li Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome caused by germline mutations in TP53. TP53 is the most common mutated gene in human cancer, occurring in 30–50% of glioblastomas (GBM). Here, we highlight a precision medicin
Externí odkaz:
https://doaj.org/article/9dc85f09d7834fddbaa84d2a1a8e9843
Autor:
Omar Abdel-Wahab, Filip Janku, Mark G. Erlander, Razelle Kurzrock, José Baselga, Funda Meric-Bernstam, Neal Rosen, Mario E. Lacouture, Raajit Rampal, Young Rock Chung, Maria E. Arcila, Timothy T. Lu, Goran Cabrilo, Veronica R. Holley, Minal Patel, Jason C. Poole, Latifa Hassaine, Cecile Rose T. Vibat, Eli L. Diamond, David M. Hyman
Supplemental Figure 1: BRAFV600E mutant allele burden in cell-free DNA (cfDNA) of urine and plasma from treatment naïve patients based on BRAFV600E tissue genotype result.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a277f843ce038a80eacf835c55f496a
https://doi.org/10.1158/2159-8290.22529876.v1
https://doi.org/10.1158/2159-8290.22529876.v1
Autor:
Omar Abdel-Wahab, Filip Janku, Mark G. Erlander, Razelle Kurzrock, José Baselga, Funda Meric-Bernstam, Neal Rosen, Mario E. Lacouture, Raajit Rampal, Young Rock Chung, Maria E. Arcila, Timothy T. Lu, Goran Cabrilo, Veronica R. Holley, Minal Patel, Jason C. Poole, Latifa Hassaine, Cecile Rose T. Vibat, Eli L. Diamond, David M. Hyman
Supplemental Figure 2: Radiographic, histologic, and molecular evaluation of KRASG12S mutant patient with Erdheim-Chester Disease (ECD).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e762a21c526c3d7637ce66bf1ece2c9
https://doi.org/10.1158/2159-8290.22529873.v1
https://doi.org/10.1158/2159-8290.22529873.v1
Autor:
Omar Abdel-Wahab, Filip Janku, Mark G. Erlander, Razelle Kurzrock, José Baselga, Funda Meric-Bernstam, Neal Rosen, Mario E. Lacouture, Raajit Rampal, Young Rock Chung, Maria E. Arcila, Timothy T. Lu, Goran Cabrilo, Veronica R. Holley, Minal Patel, Jason C. Poole, Latifa Hassaine, Cecile Rose T. Vibat, Eli L. Diamond, David M. Hyman
Supplemental Table 3: Plasma and urine cfDNA mutation detection zscores for KRAS (G12A, G12C, G12D, G12R, G12S, G12V, G13D) with tissue biopsy KRASG12 genotyping from patient with Erdheim-Chester Disease (ECD).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd72dc0328866fed3c6fd44cf7b7e83
https://doi.org/10.1158/2159-8290.22529864
https://doi.org/10.1158/2159-8290.22529864
Autor:
Omar Abdel-Wahab, Filip Janku, Mark G. Erlander, Razelle Kurzrock, José Baselga, Funda Meric-Bernstam, Neal Rosen, Mario E. Lacouture, Raajit Rampal, Young Rock Chung, Maria E. Arcila, Timothy T. Lu, Goran Cabrilo, Veronica R. Holley, Minal Patel, Jason C. Poole, Latifa Hassaine, Cecile Rose T. Vibat, Eli L. Diamond, David M. Hyman
Supplemental Table 1: Concordance of initial urinary cell-free DNA (cfDNA) assessment of BRAFV600E mutation with tissue biopsy BRAFV600E result.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122fb8c10e8183a8f7c9fd0ef860ebba
https://doi.org/10.1158/2159-8290.22529870.v1
https://doi.org/10.1158/2159-8290.22529870.v1
Autor:
Omar Abdel-Wahab, Filip Janku, Mark G. Erlander, Razelle Kurzrock, José Baselga, Funda Meric-Bernstam, Neal Rosen, Mario E. Lacouture, Raajit Rampal, Young Rock Chung, Maria E. Arcila, Timothy T. Lu, Goran Cabrilo, Veronica R. Holley, Minal Patel, Jason C. Poole, Latifa Hassaine, Cecile Rose T. Vibat, Eli L. Diamond, David M. Hyman
Supplemental Table 2: Concordance of initial plasma cell-free DNA (cfDNA) assessment of BRAFV600E mutations with tissue biopsy BRAFV600E result.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58763b9b3754a12c584f21d87c00771f
https://doi.org/10.1158/2159-8290.22529867
https://doi.org/10.1158/2159-8290.22529867
Autor:
Filip Janku, Alberto Bardelli, Heinz-Josef Lenz, Salvatore Siena, Funda Meric-Bernstam, E. Scott Kopetz, Rajyalakshmi Luthra, Mark G. Erlander, Vladislava O. Melnikova, David Berz, Saege Hancock, Cecile Rose T. Vibat, Sandeep Pingle, Federica Di Nicolantonio, Silvio Veronese, Helen J. Huang, Apostolia M. Tsimberidou, Vivek Subbiah, Sarina A. Piha-Paul, Daniel D. Karp, Giulia Siravegna, Andrea Cassingena, Andrea Sartore-Bianchi, Afsaneh Barzi, Takeo Fujii
Purpose: Tumor-derived cell-free DNA (cfDNA) from urine of patients with cancer offers noninvasive biological material for detection of cancer-related molecular abnormalities such as mutations in Exon 2 of KRAS.Experimental Design: A quantitative, mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bae4dcbd1ca12015fcf0a7154e584d4
https://doi.org/10.1158/1078-0432.c.6526212
https://doi.org/10.1158/1078-0432.c.6526212
Autor:
Filip Janku, Alberto Bardelli, Heinz-Josef Lenz, Salvatore Siena, Funda Meric-Bernstam, E. Scott Kopetz, Rajyalakshmi Luthra, Mark G. Erlander, Vladislava O. Melnikova, David Berz, Saege Hancock, Cecile Rose T. Vibat, Sandeep Pingle, Federica Di Nicolantonio, Silvio Veronese, Helen J. Huang, Apostolia M. Tsimberidou, Vivek Subbiah, Sarina A. Piha-Paul, Daniel D. Karp, Giulia Siravegna, Andrea Cassingena, Andrea Sartore-Bianchi, Afsaneh Barzi, Takeo Fujii
Supplementary methods. Supplementary Table S1. Verification of the analytical sensitivity (lower limit of detection) of the KRASG12/G13 mutation-enrichment NGS assay. Supplementary Table S2. KRASG12/G13 mutations in archival tumor tissue, urine cell-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c1823f44086d77240d0ae850cd3c26
https://doi.org/10.1158/1078-0432.22465998
https://doi.org/10.1158/1078-0432.22465998